Slowed Processing Speed Disrupts Patient Expectancy in Late Life Depression.
Late life depression
antidepressants
executive dysfunction
expectancy
processing speed
Journal
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
ISSN: 1545-7214
Titre abrégé: Am J Geriatr Psychiatry
Pays: England
ID NLM: 9309609
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
10
07
2020
revised:
30
10
2020
accepted:
02
11
2020
pubmed:
1
12
2020
medline:
24
8
2021
entrez:
30
11
2020
Statut:
ppublish
Résumé
Slowed processing speed and executive dysfunction are associated with poor outcomes in Late Life Depression (LLD), though it is unclear why. We investigated whether these variables interfere with the development of positive treatment expectancies in an antidepressant trial. Depressed older subjects were randomized to Open (intended to increase patient expectancy) or Placebo-controlled (termed 'Hidden,' intended to decrease expectancy) administration of antidepressant medication for 8 weeks. Analysis of covariance analyzed the between-group difference on expectancy (Credibility and Expectancy Scale [CES]) and depression (Hamilton Rating Scale for Depression [HRSD], Clinical Global Impressions [CGI] Severity). Moderator analyses examined whether these Open versus Hidden differences varied based on higher versus lower processing speed and executive function. Among the 108 participants, a significant between-group difference was observed on expectancy (effect size [ES, Cohen's d] = 0.51 on CES Item 2; ES = 0.64 on Item 4), indicating the manipulation was effective. Processing speed as measured by the Stroop Color-Word Test (number color-words named in congruent condition) was a significant moderator of the Open versus Hidden effect on expectancy. Depressive symptom improvement was greater on average for Open versus Hidden participants who received active drug (CGI-severity ES = 1.25, HRSD ES = 0.41), but no neurocognitive moderators of the between-group difference reached statistical significance. Slowed processing speed impairs the development of expectancies in antidepressant trials for LLD, which may help explain lower antidepressant response among older adults. Future studies may address whether interventions to optimize treatment expectancies are capable of improving treatment outcomes.
Identifiants
pubmed: 33250338
pii: S1064-7481(20)30542-X
doi: 10.1016/j.jagp.2020.11.001
pmc: PMC8099936
mid: NIHMS1650113
pii:
doi:
Substances chimiques
Antidepressive Agents
0
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
619-630Subventions
Organisme : NIMH NIH HHS
ID : R01 MH102293
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : ErratumIn
Informations de copyright
Copyright © 2020 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.
Références
Am J Psychiatry. 2013 Jul;170(7):723-33
pubmed: 23318413
Am J Psychiatry. 2017 Feb 1;174(2):135-142
pubmed: 27609242
Arch Gen Psychiatry. 2004 Jun;61(6):587-95
pubmed: 15184238
Mol Psychiatry. 2011 Jul;16(7):738-50
pubmed: 21483429
Am J Geriatr Psychiatry. 2008 Jan;16(1):65-73
pubmed: 17998306
JAMA Psychiatry. 2015 Nov;72(11):1087-94
pubmed: 26421634
J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86
pubmed: 11132119
Am J Geriatr Psychiatry. 1999 Fall;7(4):309-16
pubmed: 10521163
Eur Neuropsychopharmacol. 2009 Jan;19(1):34-40
pubmed: 18823760
Am J Geriatr Psychiatry. 2016 Jan;24(1):31-41
pubmed: 26282222
J Clin Psychopharmacol. 2009 Aug;29(4):372-7
pubmed: 19593178
J Consult Clin Psychol. 2002 Aug;70(4):1051-5
pubmed: 12182269
Am J Geriatr Psychiatry. 2013 Jul;21(7):675-84
pubmed: 23567401
Lancet Psychiatry. 2016 May;3(5):425-35
pubmed: 26995298
JAMA. 2008 May 28;299(20):2391-400
pubmed: 18505948
Biol Psychiatry. 2006 Jul 1;60(1):58-65
pubmed: 16414031
Am J Psychiatry. 2020 Jun 1;177(6):548-555
pubmed: 32212856
Biol Psychiatry. 2001 Nov 1;50(9):651-8
pubmed: 11704071
Psychiatry Res. 2011 Aug 30;193(2):101-6
pubmed: 21680159
Neuroimage. 2006 Jul 15;31(4):1487-505
pubmed: 16624579
J Clin Psychiatry. 2010 Mar;71(3):270-9
pubmed: 20122371
Arch Gen Psychiatry. 1996 Apr;53(4):305-12
pubmed: 8634008
Biol Psychiatry. 2008 Sep 15;64(6):491-7
pubmed: 18490003
J Am Geriatr Soc. 2009 Apr;57(4):594-603
pubmed: 19220558
Int J Neuropsychopharmacol. 2016 Jun 15;19(10):
pubmed: 27312740
Psychol Rev. 1996 Jul;103(3):403-28
pubmed: 8759042
Neuroimage. 2004;23 Suppl 1:S208-19
pubmed: 15501092
Psychol Bull. 2004 Mar;130(2):324-40
pubmed: 14979775
Eur J Appl Physiol. 2008 Mar;102(4):371-80
pubmed: 17960416
Neurology. 2018 Oct 9;91(15):e1402-e1412
pubmed: 30217936
J Clin Psychiatry. 2004 Sep;65(9):1174-9
pubmed: 15367043
Psychol Med. 2013 May;43(5):975-82
pubmed: 22971472
Psychother Psychosom. 2009;78(3):172-81
pubmed: 19321970
Curr Psychiatry Rev. 2010 Feb 1;6(1):1-10
pubmed: 24812548
JAMA. 2002 Nov 13;288(18):2271-81
pubmed: 12425704
J Psychiatr Res. 2003 Mar-Apr;37(2):99-108
pubmed: 12842163